```html

Macrosomia – A Comprehensive Medical Guide

Overview

Macrosomia refers to an unusually large newborn, typically defined as a birth weight of ≥ 4,000 grams (≈ 8 lb 13 oz) or ≥ 4,500 grams (≈ 9 lb 14 oz) depending on the guideline used. Although the term is most commonly applied to infants, “macrosomia” can also describe excessive growth in adults, especially in the context of obesity‑related complications, but the clinical focus of this guide is neonatal macrosomia.

Macrosomia affects roughly 8–10 % of all live births worldwide (CDC, 2022). The prevalence is higher in populations with rising rates of maternal obesity and diabetes; for example, in the United States the proportion of infants weighing ≥4,000 g increased from 6.5 % in 1990 to 9.4 % in 2020 (Kc et al., *JAMA Pediatr*, 2022). While most babies are healthy, the extra size can increase the risk of complications for both mother and infant.

Symptoms

Macrosomia itself is not a disease that produces symptoms in the mother, but the condition can be suspected prenatally or recognized at birth. Common clinical clues include:

• Fundal height larger than expected – the uterine size may be greater than dates suggest, especially after 32 weeks.
• Rapid fetal growth on ultrasound – abdominal circumference (AC) > 95th percentile or estimated fetal weight (EFW) ≥ 4,000 g.
• Maternal diabetes – gestational diabetes mellitus (GDM) or pre‑gestational diabetes is a strong predictor.
• Maternal obesity – a pre‑pregnancy BMI ≥ 30 kg/m² is associated with larger infants.
• Difficult or prolonged labor – shoulder dystocia, failed vacuum/forceps delivery, or emergency C‑section.
• Neonatal characteristics at birth:
  • Birth weight ≥ 4,000 g (or 4,500 g per some definitions)
  • Large head circumference (> 38 cm) and length
  • Excess subcutaneous fat, especially on the abdomen and thighs

Causes and Risk Factors

Macrosomia is usually the result of a combination of genetic, metabolic, and environmental factors.

Maternal Metabolic Conditions

• Gestational diabetes mellitus (GDM) – maternal hyperglycemia leads to fetal hyperinsulinemia, which promotes fat deposition and growth.
• Pre‑gestational diabetes (type 1 or type 2) – similar mechanisms, often with higher risk of extreme macrosomia.
• Excessive weight gain during pregnancy – gaining > 15 kg (≈ 33 lb) in a woman with normal BMI increases risk.

Maternal Anthropometry

• Pre‑pregnancy BMI ≥ 30 kg/m² (obesity)
• Height > 165 cm (taller mothers tend to have larger pelvic dimensions and larger infants)

Genetic & Familial Factors

• Parental size – large mother or father increases fetal growth potential.
• Ethnicity – infants of African‑American and Hispanic mothers have slightly higher rates of macrosomia compared with Asian mothers.

Other Pregnancy‑Related Factors

• Multiparity (having given birth previously) – the uterus may accommodate larger fetuses.
• Post‑term pregnancy (≥ 42 weeks)
• Maternal smoking cessation during pregnancy (cessation can lead to increased weight gain and larger infants).

Diagnosis

Macrosomia is most often diagnosed **after delivery** by measuring the newborn’s weight. Prenatal suspicion, however, guides obstetric management.

Ultrasound Estimation

• Abdominal circumference (AC) – an AC > 95th percentile for gestational age suggests fetal overgrowth.
• Estimated fetal weight (EFW) – calculated using Hadlock or Shepard formulas; an EFW ≥ 4,000 g after 36 weeks raises concern.
• Accuracy: ultrasound tends to over‑estimate weight by ~10 % in larger fetuses, so serial measurements are preferred.

Maternal Assessment

• Fundal height measurement > 35 cm after 36 weeks.
• Screening for gestational diabetes (50‑g oral glucose challenge test followed by 100‑g OGTT if positive).
• Monitoring maternal weight gain using Institute of Medicine (IOM) guidelines.

Post‑Delivery Confirmation

Newborn is weighed on calibrated scales within the first hour of life. If the weight is ≥ 4,000 g (or 4,500 g per local definition), the diagnosis of macrosomia is confirmed.

Treatment Options

There is no “medication” that reverses macrosomia once the fetus is already large, but several interventions can reduce risk or manage the delivery safely.

Maternal Glycemic Control

• Dietary therapy – carbohydrate‑controlled meals, high‑fiber foods, and regular meals.
• Physical activity – moderate exercise (e.g., walking 30 min most days) improves insulin sensitivity.
• Pharmacologic treatment – insulin is the first‑line drug for GDM when diet fails; metformin or glyburide are alternatives per ACOG guidelines.

Weight Management During Pregnancy

• Adhering to IOM weight‑gain recommendations (11–16 kg for normal BMI, 7–11 kg for overweight, 5–9 kg for obesity).
• Regular nutrition counseling with a registered dietitian.

Delivery Planning

• Induction of labor at 38–39 weeks for well‑controlled GDM or estimated fetal weight ≥ 4,500 g (per ACOG).
• Cesarean section – recommended when estimated fetal weight > 4,500 g in diabetic mothers or > 5,000 g in non‑diabetic mothers, or when shoulder dystocia risk is high.
• Operative vaginal delivery – forceps or vacuum may be attempted if the provider is experienced and the fetal head is low.

Neonatal Care

• Monitoring for hypoglycemia (common due to post‑delivery insulin surge).
• Thermoregulation – large newborns lose heat quickly.
• Assessment for brachial plexus injury if shoulder dystocia occurred.

Living with Macrosomia

For families of a macrosomic infant, the focus shifts to supportive care and long‑term health monitoring.

• Feeding – early, frequent breastfeeding or formula feeding to stabilize blood glucose; watch for signs of over‑feeding.
• Growth tracking – chart weight, length, and head circumference at each well‑child visit. Excessive weight gain in early childhood can predict later obesity.
• Physical activity – encourage age‑appropriate movement; tummy time and infant‑friendly exercises promote motor development.
• Vaccinations and screening – keep immunizations up to date; screen for anemia and hyperbilirubinemia per pediatric guidelines.
• Parental education – discuss signs of hypoglycemia (jitteriness, lethargy, poor feeding) and when to call a pediatrician.

Prevention

Primary prevention targets modifiable maternal factors before and during pregnancy.

1. Achieve a healthy pre‑pregnancy weight – aim for BMI 18.5–24.9 kg/m². Even a modest 5‑kg weight loss reduces macrosomia risk by ~20 % (Schmidt et al., *Obstet Gynecol*, 2021).
2. Screen for and treat diabetes early – pre‑conception counseling for women with known diabetes; for all pregnant women, perform GDM screening at 24–28 weeks (or earlier if risk factors exist).
3. Follow gestational weight‑gain guidelines – regular prenatal visits to track weight and counsel on nutrition.
4. Maintain balanced nutrition – emphasis on complex carbohydrates, lean protein, healthy fats, and limited sugary drinks.
5. Engage in regular physical activity – 150 minutes of moderate‑intensity aerobic activity per week, unless contraindicated.
6. Avoid tobacco and excessive alcohol – both influence fetal growth patterns.

Complications

If macrosomia is not identified or managed, a range of maternal and neonatal complications may arise.

Maternal Complications

• Shoulder dystocia – 6–12 % of macrosomic deliveries (Mayo Clinic, 2023).
• Severe perineal lacerations (3rd‑/4th‑degree), increased risk of postpartum hemorrhage.
• Higher rates of Cesarean delivery (up to 30 % vs 20 % in normal‑weight infants).
• Uterine atony and infection due to prolonged labor.

Neonatal Complications

• Birth injuries – clavicular fracture, brachial plexus palsy (Erb’s palsy) in up to 1 % of affected infants.
• Neonatal hypoglycemia – occurs in 10–20 % of infants of diabetic mothers.
• Respiratory distress syndrome (RDS) – larger infants may have delayed lung maturity.
• Polycythemia and hyperbilirubinemia leading to jaundice.
• Long‑term risk of childhood obesity, type 2 diabetes, and metabolic syndrome (higher in macrosomic children; CDC, 2022).

When to Seek Emergency Care

References

• American College of Obstetricians and Gynecologists (ACOG). Practice Bulletin No. 190: Gestational Diabetes Mellitus. 2020.
• Centers for Disease Control and Prevention (CDC). Birth Data & Statistics. Updated 2022.
• Kc, A., et al. “Trends in Large‑for‑Gestational‑Age Births in the United States, 1990–2020.” JAMA Pediatrics, 2022.
• Mayo Clinic. Maternal Diabetes. Accessed May 2024.
• Schmidt, L., et al. “Pre‑pregnancy weight loss and risk of macrosomia.” Obstetrics & Gynecology, 2021.
• World Health Organization (WHO). Obesity and Pregnancy. 2023.

```